Table 2.
Clinical and echocardiographic characteristics in dialysis and non-dialysis patients
| Non-dialysis | Dialysis | P value | |
|---|---|---|---|
| Number |
96 |
57 |
NA |
| Mean age |
69.7 ± 11.7 |
58.7 ± 15.0 |
<0.0001 |
| Female sex |
40 (42%) |
25 (44%) |
NS |
| Diabetes |
45 (47%) |
24 (42%) |
NS |
| History of MI |
18 (19%) |
12 (21%) |
NS |
|
Blood indices: |
|
|
|
| Haemoglobin (g/L) |
123.8 ± 15.4 |
117.0 ± 12.3 |
0.0058 |
| White cell count |
7.38 ± 2.0 |
7.57 ± 2.13 |
NS |
| Platelet count |
238 ± 63 |
232 ± 88 |
NS |
| Sodium |
139.9 ± 2.6 |
137.4± |
<0.0001 |
| Potassium |
4.46 ± 0.59 |
4.41± |
NS |
| Urea (mmol/L) |
18.9 ± 6.9 |
19.2 ± 6.7 |
NS |
| Creatinine (umol/L) |
255 ± 88 |
646 ± 229 |
<0.0001 |
| eGFR (mL/min/1.73 m2) |
22.3 ± 7.4 |
8.3 ± 4.9 |
<0.0001 |
| Calcium (mmol/L) |
2.40 ± 0.12 |
2.38 ± 0.17 |
NS |
| Phosphate (mmol/L) |
1.31 ± 0.29 |
1.84 ± 0.55 |
<0.0001 |
| Parathyroid hormane |
23.6 ± 29.1 |
51.4 ± 48.6 |
<0.0001 |
| Troponin T detected |
36 (38%) |
44 (79%) |
<0.001 |
|
Echocardiographic results |
|
|
|
| LV diameter (mm) |
49.5 ± 5.9 |
49.8 ± 6.2 |
NS |
| LV ejection fraction |
62.1 ± 10.0 |
61.0 ± 14.0 |
NS |
| LV mass index |
121.7 ± 35.4 |
126.8 ± 33.6 |
NS |
| Left atrial area (cm2) |
22.1 ± 6.0 |
21.6 ± 4.9 |
NS |
| Aortic peak velocity (m/s) |
1.50 ± 0.42 |
1.57 ± 0.47 |
NS |
| Mitral regurgitation (moderate or severe) |
8 (8.3%) |
6 (10.5%) |
NS |
| Tricuspid regurgitation peak velocity (m/s) |
2.53 ± 0.44 |
2.59 ± 0.45 |
NS |
|
Diastolic grade: |
|
|
|
| Grade 0 |
14 (16.3%) |
7 (13.7%) |
NS |
| Grade 1 |
48 (55.8%) |
24 (47.1%) |
NS |
| Grade 2 |
16 (18.6%) |
15 (29.4%) |
NS |
| Grade 3-4 |
8 (9.3%) |
5 (9.8%) |
NS |
| Indeterminate grade |
9 (9.5%) |
7 (12.1%) |
NS |
|
Clinical outcomes |
|
|
|
| Death |
23 (24.0%) |
18 (31.6%) |
NS |
| MACE | 27 (28.1%) | 24 (42.1%) | 0.06 |
LVEF, Left ventricular ejection fraction; LVMI, Left ventricular mass index; MACE, Major adverse cardiovascular events, diastolic function was classified into grades 1–4 according to the ASE guidelines.